June 12, 2014npj Primary Care Respiratory MedicineOpen Access

The prevalence of COPD co-morbidities in Serbia: results of a national survey

View Full Paper

Ask AI

Bookmark

Why the study?

What is the prevalence of co-morbidities and functional limitations in subjects with COPD compared to those without COPD in Serbia?

Population

10,013 respondents aged 40 years or older from a nationally representative sample of the population of…

Design

Cross-sectional

Authors

LNLjudmila Nagorni-ObradovićUniversity of Belgrade DVDejana VukovićUniversity of Belgrade

Discussion

Member takes

Implication

Higher comorbidity burden in COPD supports screening; leaves open causal links and practice changes pending longitudinal data.

Structured PICO

What is the prevalence of co-morbidities and functional limitations in subjects with COPD compared to those without COPD in Serbia?

Population

10,013 respondents aged 40 years or older from a nationally representative sample of the population of Serbia, including 653 subjects with COPD and 9,360 respondents without COPD.

Comparator

Respondents without COPD (n=9,360)

Outcome

Prevalence of co-morbidities and functional limitations

COPD patients in Serbia have a significantly higher burden of co-morbidities, particularly hypertension and dyslipidaemia, highlighting the need for comprehensive co-morbidity assessment in this population.

Cite This Study

Nagorni-Obradović et al. (2014) studied this question.

synapsesocial.com/papers/6a7a8b8a1bd2924d66f3944a https://doi.org/10.1038/npjpcrm.2014.8

Topics

Hypertension management Lipid management

View Full Paper

Ask AI

Bookmark

The prevalence of COPD co-morbidities in Serbia: results of a national survey

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

The prevalence of COPD co-morbidities in Serbia: results of a national survey

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider